Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Atara Biotherapeutics Stock Price (Quote) NASDAQ:ATRA
$16.07 ( 12.93% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $13.93 | $17.75 | Friday, 14th Jan 2022 ATRA stock ended at $16.07. This is 12.93% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 12.87% from a day low at $14.38 to a day high of $16.23. |
| 90 days | $13.93 | $20.04 | |
| 52 weeks | $11.81 | $21.85 |
Historical Atara Biotherapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $14.40 | $16.23 | $14.38 | $16.07 | 1 811 488 |
| 2022-01-13 | $14.44 | $14.76 | $13.93 | $14.23 | 598 310 |
| 2022-01-12 | $15.46 | $15.57 | $14.33 | $14.39 | 521 811 |
| 2022-01-11 | $15.76 | $16.08 | $15.34 | $15.44 | 687 218 |
| 2022-01-10 | $15.29 | $16.02 | $15.08 | $15.88 | 877 339 |
| 2022-01-07 | $15.99 | $16.44 | $15.50 | $15.71 | 1 030 283 |
| 2022-01-06 | $15.54 | $16.15 | $15.38 | $15.98 | 877 000 |
| 2022-01-05 | $15.96 | $16.59 | $15.54 | $15.58 | 1 394 494 |
| 2022-01-04 | $16.76 | $16.91 | $16.02 | $16.27 | 572 009 |
| 2022-01-03 | $16.01 | $16.93 | $15.68 | $16.89 | 821 800 |
| 2021-12-31 | $16.30 | $16.55 | $15.68 | $15.76 | 324 681 |
| 2021-12-30 | $17.34 | $17.39 | $16.08 | $16.12 | 495 318 |
| 2021-12-29 | $17.47 | $17.47 | $16.89 | $17.04 | 266 419 |
| 2021-12-28 | $17.14 | $17.75 | $17.14 | $17.24 | 667 222 |
| 2021-12-27 | $17.21 | $17.23 | $16.91 | $17.13 | 612 511 |
| 2021-12-23 | $16.34 | $17.50 | $16.34 | $17.31 | 679 889 |
| 2021-12-22 | $15.62 | $16.41 | $15.28 | $16.35 | 1 381 965 |
| 2021-12-21 | $15.72 | $15.91 | $15.12 | $15.56 | 984 158 |
| 2021-12-20 | $15.15 | $15.73 | $14.69 | $15.69 | 1 860 965 |
| 2021-12-17 | $15.18 | $15.62 | $14.77 | $15.15 | 2 223 643 |
| 2021-12-16 | $16.18 | $16.47 | $15.16 | $15.27 | 642 716 |
| 2021-12-15 | $15.66 | $16.15 | $15.09 | $16.03 | 898 511 |
| 2021-12-14 | $15.40 | $16.05 | $15.19 | $15.71 | 935 341 |
| 2021-12-13 | $16.04 | $16.20 | $15.26 | $15.66 | 624 880 |
| 2021-12-10 | $16.55 | $16.93 | $15.74 | $15.98 | 749 897 |
| 2021-12-09 | $17.33 | $17.51 | $16.13 | $16.31 | 930 274 |
| 2021-12-08 | $17.99 | $18.03 | $17.41 | $17.52 | 775 809 |
| 2021-12-07 | $17.00 | $18.31 | $17.00 | $17.89 | 712 509 |
| 2021-12-06 | $17.00 | $17.43 | $16.36 | $16.98 | 696 566 |
| 2021-12-03 | $18.19 | $18.26 | $16.83 | $17.09 | 620 404 |
| 2021-12-02 | $17.03 | $18.12 | $17.03 | $18.01 | 486 957 |
| 2021-12-01 | $18.05 | $18.61 | $17.35 | $17.36 | 902 072 |
| 2021-11-30 | $17.65 | $17.98 | $17.23 | $17.89 | 444 266 |
| 2021-11-29 | $17.57 | $18.35 | $17.49 | $17.79 | 760 670 |
| 2021-11-26 | $17.81 | $18.07 | $17.03 | $17.57 | 414 324 |
| 2021-11-24 | $17.97 | $18.18 | $17.61 | $18.15 | 339 526 |
| 2021-11-23 | $18.13 | $18.20 | $17.12 | $18.07 | 657 127 |
| 2021-11-22 | $18.46 | $18.85 | $18.10 | $18.19 | 495 246 |
| 2021-11-19 | $17.67 | $18.50 | $17.50 | $18.30 | 543 979 |
| 2021-11-18 | $17.89 | $18.09 | $17.60 | $17.83 | 492 294 |
| 2021-11-17 | $17.30 | $17.92 | $17.30 | $17.80 | 1 369 087 |
| 2021-11-16 | $16.47 | $17.45 | $16.30 | $17.37 | 1 007 295 |
| 2021-11-15 | $17.64 | $18.00 | $16.95 | $17.07 | 1 573 870 |
| 2021-11-12 | $17.62 | $17.77 | $17.35 | $17.62 | 848 436 |
| 2021-11-11 | $17.53 | $17.80 | $17.37 | $17.54 | 552 433 |
| 2021-11-10 | $17.70 | $18.11 | $17.21 | $17.30 | 428 227 |
| 2021-11-09 | $17.71 | $18.04 | $17.38 | $17.93 | 675 787 |
| 2021-11-08 | $18.34 | $18.45 | $17.40 | $17.64 | 1 740 079 |
| 2021-11-05 | $19.46 | $19.46 | $18.09 | $18.17 | 871 254 |
| 2021-11-04 | $18.37 | $20.04 | $18.08 | $19.89 | 963 541 |
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with severe and life-threatening diseases. Its products under development include EBV-CTL, which is Phase II clinical trials for the treatment of malignancies associated with Epstein Barr Virus (EBV), including EBV-associated post-transplant lymphoproliferative disorders; CMV-CTL that is in Phase II clinical trials for the treatme... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
